医学
结直肠癌
危险分层
肿瘤科
佐剂
辅助化疗
随机对照试验
化疗
内科学
癌症
乳腺癌
作者
Claus L. Andersen,Ellen Heitzer
出处
期刊:Cancer Cell
[Elsevier]
日期:2022-09-01
卷期号:40 (9): 911-913
被引量:1
标识
DOI:10.1016/j.ccell.2022.08.017
摘要
In stage II colorectal cancer, adjuvant chemotherapy is controversial, and overtreatment is substantial due to suboptimal risk stratification. In a recent New England Journal of Medicine article reporting from a prospective randomized phase II trial, Tie and colleagues demonstrate how ctDNA-guided risk-stratification reduces the use of adjuvant chemotherapy without compromising recurrence risk.
科研通智能强力驱动
Strongly Powered by AbleSci AI